Fiche d'information compilée à partir de PubMed
Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.
Compilé à partir de 30 articles PubMed · modèle : gemma4:31b
Résumé
Contexte
Usages traditionnels
Composés actifs
Preuves cliniques
Daily consumption of boiled tea for 17 months resulted in a significant decrease of 75.67% in caries incidence among schoolchildren [PMID:9462048].
A triterpene mixture from the leaves exhibited 51% analgesic activity in mice, performing similarly to mefenamic acid [PMID:15099847].
A triterpene mixture showed 29% anti-diarrheal activity at 100mg/kg and 55% activity at 250mg/kg in mice [PMID:15099847].
An isolated compound from the leaves reduced the number of micronucleated polychromatic erythrocytes induced by tetracycline by approximately 68.4% in albino mice [PMID:7678156, PMID:8425260].
Posologie et administration
Synthèse des preuves
Sources PubMed
- 1.PMID: 9462048 (1995) — Caries preventive effect of wild tea (tsaang-gubat) among school children. · The Journal of the Philippine Dental Association
- 2.PMID: 39830414 (2024) — Knowledge, Attitude, and Practices on Four Medicinal Plants for Oral Health of Oral Medicine Patients from a Dental College in Manila. · Acta medica Philippina
- 3.PMID: 8425260 (1993) — Structure of an antimutagen from Carmona retusa leaves. · Carcinogenesis
- 4.PMID: 7678156 (1993) — Antimutagen from leaves of Carmona retusa (Vahl) Masam. · Mutation research
- 5.PMID: 15099847 (2004) — Evaluation of the bioactivity of triterpene mixture isolated from Carmona retusa (Vahl.) Masam leaves.